Pliant Therapeutics, Inc. (PLRX)
0.6497
-0.01
(-1.59%)
USD |
NASDAQ |
Nov 18, 16:00
0.6497
0.00 (0.00%)
After-Hours: 20:00
Pliant Therapeutics Shareholders Equity (Quarterly) : 126.63M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 126.63M |
| June 30, 2026 | 146.93M |
| March 31, 2026 | 165.17M |
| December 31, 2025 | 181.20M |
| September 30, 2025 | 200.31M |
| June 30, 2025 | 220.08M |
| March 31, 2025 | 257.16M |
| December 31, 2024 | 304.08M |
| September 30, 2024 | 345.82M |
| June 30, 2024 | 392.68M |
| March 31, 2024 | 437.33M |
| December 31, 2023 | 473.58M |
| September 30, 2023 | 503.05M |
| June 30, 2023 | 533.06M |
| Date | Value |
|---|---|
| March 31, 2023 | 561.92M |
| December 31, 2022 | 313.34M |
| September 30, 2022 | 336.99M |
| June 30, 2022 | 147.79M |
| March 31, 2022 | 173.79M |
| December 31, 2021 | 199.06M |
| September 30, 2021 | 220.44M |
| June 30, 2021 | 243.98M |
| March 31, 2021 | 264.17M |
| December 31, 2020 | 283.06M |
| September 30, 2020 | 300.35M |
| June 30, 2020 | 315.82M |
| March 31, 2020 | 173.56M |
| December 31, 2019 | 109.98M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 57.98M |
| CorMedix, Inc. | 461.71M |
| Eloxx Pharmaceuticals, Inc. | 41.07M |
| Breakthrough Chemistry, Inc. | 0.8373M |
| BioStem Technologies, Inc. | 18.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 169.88M |
| Total Liabilities (Quarterly) | 43.24M |
| Debt to Equity Ratio | 0.2194 |
| Current Ratio | 8.047 |
| Net Debt Paydown Yield | 9.74% |